Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brandon

Showing results (401-410 of 431) with videos related to

Pageof 44
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypesMichele P Kelly, Sheree F Logue, Julie Brennan, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2016
Challenges in the development of an M<sub>4</sub> PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogsMichael R Wood, Meredith J Noetzel, Michael S Poslusney, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2017
Optimization of M<sub>4</sub> positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacologyBruce J Melancon, Michael R Wood, Meredith J Noetzel, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A bivalent lysine-acetylated small-molecule binding site in MYCDikshat G Gupta, Mihai I Truica, Adam W T Steffeck, et al.
Molecular Psychiatry|September 15, 2010
The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and functionQ Wang, E I Charych, V L Pulito, et al.
Plos Genetics|December 10, 2016
The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human IsletsMark P Keller, Pradyut K Paul, Mary E Rabaglia, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of VU0467485/AZ13713945: An M<sub>4</sub> PAM Evaluated as a Preclinical Candidate for the Treatment of SchizophreniaMichael R Wood, Meredith J Noetzel, Bruce J Melancon, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2019
VU6005806/AZN-00016130, an advanced M<sub>4</sub> positive allosteric modulator (PAM) profiled as a potential preclinical development candidateDarren W Engers, Bruce J Melancon, Allison R Gregro, et al.
Cell Reports|May 7, 2020
Variation of Human Neural Stem Cells Generating Organizer States In Vitro before Committing to Cortical Excitatory or Inhibitory Neuronal FatesNicola Micali, Suel-Kee Kim, Marcelo Diaz-Bustamante, et al.
Pageof 44

Showing results (401-410 of 431) with videos related to

Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypesMichele P Kelly, Sheree F Logue, Julie Brennan, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2016
Challenges in the development of an M<sub>4</sub> PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogsMichael R Wood, Meredith J Noetzel, Michael S Poslusney, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2017
Optimization of M<sub>4</sub> positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacologyBruce J Melancon, Michael R Wood, Meredith J Noetzel, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A bivalent lysine-acetylated small-molecule binding site in MYCDikshat G Gupta, Mihai I Truica, Adam W T Steffeck, et al.
Molecular Psychiatry|September 15, 2010
The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and functionQ Wang, E I Charych, V L Pulito, et al.
Plos Genetics|December 10, 2016
The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human IsletsMark P Keller, Pradyut K Paul, Mary E Rabaglia, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of VU0467485/AZ13713945: An M<sub>4</sub> PAM Evaluated as a Preclinical Candidate for the Treatment of SchizophreniaMichael R Wood, Meredith J Noetzel, Bruce J Melancon, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2019
VU6005806/AZN-00016130, an advanced M<sub>4</sub> positive allosteric modulator (PAM) profiled as a potential preclinical development candidateDarren W Engers, Bruce J Melancon, Allison R Gregro, et al.
Cell Reports|May 7, 2020
Variation of Human Neural Stem Cells Generating Organizer States In Vitro before Committing to Cortical Excitatory or Inhibitory Neuronal FatesNicola Micali, Suel-Kee Kim, Marcelo Diaz-Bustamante, et al.
Pageof 44